Education
About Us
Working with TipRanks
Follow Us
Claritas Pharmaceuticals Inc (CLAZF)
:CLAZF
CLAZF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume4.20K
Average Volume (3M)N/A
Market Cap
$825.73K
Enterprise Value$1.12M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta69.98
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,786,587
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.12
Price to Sales (P/S)0.00
P/FCF Ratio-0.06
Enterprise Value/Market Cap1.36
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CLAZF FAQ
What was Claritas Pharmaceuticals Inc’s price range in the past 12 months?
Claritas Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Claritas Pharmaceuticals Inc’s market cap?
Claritas Pharmaceuticals Inc’s market cap is $825.73K.
When is Claritas Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Claritas Pharmaceuticals Inc’s earnings last quarter?
Claritas Pharmaceuticals Inc released its earnings results on May 31, 2019. The company reported -$0.408 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.408.
Is Claritas Pharmaceuticals Inc overvalued?
According to Wall Street analysts Claritas Pharmaceuticals Inc’s price is currently Overvalued.
Does Claritas Pharmaceuticals Inc pay dividends?
Claritas Pharmaceuticals Inc does not currently pay dividends.
What is Claritas Pharmaceuticals Inc’s EPS estimate?
Claritas Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Claritas Pharmaceuticals Inc have?
Claritas Pharmaceuticals Inc has 37,786,587 shares outstanding.
What happened to Claritas Pharmaceuticals Inc’s price movement after its last earnings report?
Claritas Pharmaceuticals Inc reported an EPS of -$0.408 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Claritas Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in CLAZF
Company Description
Claritas Pharmaceuticals Inc
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
Artelo Biosciences
―
China Pharma Holdings
―
CytoDyn
―
Enzolytics
―
EyePoint Pharmaceuticals
―
Xencor
―